La cadena de opciones muestra datos clave de las opciones de acciones de Zeo Energy a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Zeo Energy..

Zeo Energy (NASDAQ:ZEO) Bolsa, Cadena de Opciones

Zeo Energy

Zeo Energy Corp is a vertically integrated provider of residential solar energy systems, other energy efficient equipment and related services currently serving customers in Florida, Texas, Arkansas, and Missouri. Its primary business activity is selling and installing residential solar energy systems that homeowners use to supplement the amount of usable electricity required to power their homes.

Zeo Energy Corporation - Class A Common Stock

Zeo Energy Corp

Zeons Corp

ZEON

Zeon Corp

ZEO SCIENTIFIX INC by Zeo ScientifiX Inc.

Zeo ScientifiX Inc

Banzai International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNZI#NASDAQ">BNZI</a>) reported quarterly losses of $(2.68) per share. This is a 712.12 percent decrease over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $1.08 million which missed the analyst consensus estimate of $1.20 million by 9.95 percent. This is a 2.51 percent decrease over sales of $1.11 million the same period last year.

Earnings

Earnings Misses

News

BNZI

Banzai International Q3 EPS $(2.68) Down From $(0.33) YoY, Sales $1.08M Miss $1.20M Estimate

FBYD

Falcons Beyond Global Q3 EPS $0.46, Sales $2.07M Up From $1.58M YoY

Chardan Capital analyst Geulah Livshits maintains Taysha Gene Therapies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSHA#NASDAQ">TSHA</a>) with a Buy and maintains $7 price target.

Price Target

Analyst Ratings

TSHA

Chardan Capital Maintains Buy on Taysha Gene Therapies, Maintains $7 Price Target

Adagio Medical Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADGM#NASDAQ">ADGM</a>) reported quarterly earnings of $0.02 per share. This is a 100.14 percent increase over losses of $(14.15) per share from the same period last year. The company reported $132.00 thousand in sales this quarter. This is a 221.95 percent increase over sales of $41.00 thousand the same period last year.

ADGM

Adagio Medical Holdings Q3 EPS $0.02 Up From $(14.15) YoY, Sales $132.00K Up From $41.00K YoY

Chardan Capital analyst Daniil Gataulin maintains CervoMed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRVO#NASDAQ">CRVO</a>) with a Buy and maintains $55 price target.

CRVO

Chardan Capital Maintains Buy on CervoMed, Maintains $55 Price Target

The Company will carefully analyze this expression of interest, decide on next steps, and inform the capital market in accordance with the legal requirements.

HALO

Evotec Confirms Receipt Of Non-binding Expression Of Interest From Halozyme Therapeutics With An Offer Price Of EUR 11.00 Per Share

PEDEVCO (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PED#AMEX">PED</a>) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $0.01 by 200 percent. The company reported quarterly sales of $9.100 million which beat the analyst consensus estimate of $8.859 million by 2.72 percent. This is a 24.15 percent increase over sales of $7.330 million the same period last year.

Earnings Beats

PEDEVCO Q3 2024 GAAP EPS $0.03 Beats $0.01 Estimate, Sales $9.100M Beat $8.859M Estimate

Forte Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBRX#NASDAQ">FBRX</a>) reported quarterly losses of $(4.54) per share which beat the analyst consensus estimate of $(7.12) by 36.24 percent. This is a 30.9 percent increase over losses of $(6.57) per share from the same period last year.

FBRX

Forte Biosciences Q3 EPS $(4.54) Beats $(7.12) Estimate

Jefferies analyst Omar Nokta maintains Safe Bulkers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SB#NYSE">SB</a>) with a Buy and maintains $6 price target.

Jefferies Maintains Buy on Safe Bulkers, Maintains $6 Price Target

Reviva Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVPH#NASDAQ">RVPH</a>) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.26) by 3.85 percent. This is a 47.92 percent increase over losses of $(0.48) per share from the same period last year.

RVPH

Reviva Pharmaceuticals Q3 2024 GAAP EPS $(0.25) Beats $(0.26) Estimate

Nova Lifestyle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVFY#NASDAQ">NVFY</a>) reported quarterly losses of $(0.72) per share. This is a 13.25 percent increase over losses of $(0.83) per share from the same period last year. The company reported $2.62 million in sales this quarter. This is a 5.65 percent increase over sales of $2.48 million the same period last year.

NVFY

Nova Lifestyle Q3 EPS $(0.72) Up From $(0.83) YoY, Sales $2.62M Up From $2.48M YoY

Hedge Funds

General

FLUT

SPOT

ValueAct Holdings' Q3 2024 13F Filing Reveals Full Exits From Spotify, Fiserv, KKR & Co., New York Times With 1.34M Shares, And Flutter Entertainment

COLL

COLLEGIUM PHARMACEUTICAL Announced That Health Canada Has Approved Its Drug Jornay-PM For The Treatment Of ADHD In Children

Palantir Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) shares are trading higher in Thursday&#8217;s after-hours session after the company announced it will transfer its stock listing <a href="https://www.benzinga.com/pressreleases/24/11/b41988795/palantir-announces-transfer-of-stock-exchange-listing-to-nasdaq">to the Nasdaq</a>.
What Happened: After the market close on Thursday, Palantir announced that it would transfer the listing of its Class A common stock from the New York Stock Exchange to the Nasdaq Global Select Market.
Palantir said it expects to begin trading as a Nasdaq-listed company on Nov. 26. The stock will continue to trade under the ticker symbol &#8220;PLTR.&#8221;
&#8220;Upon transferring, Palantir anticipates meeting the eligibility requirements of the Nasdaq-100 Index,&#8221; the company said.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41984278/jim-simons-renaissance-technologies-shifts-gears-microsoft-in-tesla-out-palantir-on-top">Jim Simons&#8217; Renaissance Technologies Shifts Gears: Microsoft In, Tesla Out, Palantir On Top</a>
Palantir has been one of the hottest stocks of the year, having gained approximately 245% year-to-date, driven by the company&#8217;s positioning in the <a href="http://benzinga.com/topic/ai">AI</a> space. 
Palantir shares really took off at the beginning of November after the company reported <a href="https://www.benzinga.com/news/earnings/24/11/41730179/palantir-q3-earnings-revenue-beat-eps-beat-customers-up-39-raises-guidance-results-driven-by-unrele">strong quarterly results</a> driven by&nbsp;"unrelenting" AI demand. 
Revenue jumped 30% year-over-year on continued strength in the U.S. customer count grew 39% year-over-year after the company closed 104 deals worth over $1 million during the quarter.
"The growth of our business is accelerating, and our financial performance is exceeding expectations as we meet an unwavering demand for the most advanced artificial intelligence technologies from our U.S. government and commercial customers,&#8221;&nbsp;Alex Karp, co-founder and CEO of Palantir, said in a letter to shareholders.
PLTR Price Action: Palantir shares were up 3.87% in after-hours, trading at $61.47 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

After-Hours Center

Movers

Tech

PLTR

Palantir Stock Is Rising After The Bell: What's Going On?

Trading Ideas

GOOG

GOOGL

Pershing Square Capital's Q3 2024 13F Filing Reveals Reduced Stakes In Hilton Worldwide By 18% To 7.37M Shares, Chipotle Mexican Grill By 8%, Restaurant Brands Intl By 1% To 23.0M Shares, And Alphabet Class C And Class A By 9%

Pershing Square Capital's Q3 2024 13F Filing Shows New Stakes In Brookfield Corp With 25.88M Shares, Nike With 13.24M Shares, And Seaport Entertainment Group With 2.09M Shares Each In Common Stock And Rights

RBLX

ValueAct Holdings' Q3 2024 13F Filing Indicates Increased Stakes In Walt Disney By 22% To 7.46M Shares And Roblox By 341% To 10.14M Shares

LLYVA

LLYVK

ValueAct Holdings' Q3 2024 13F Filing Shows New Stakes In Meta Platforms With 211.5K Shares, Live Nation Entertainment With 1.01M Shares, Visa With 373.6K Shares, Liberty Media Corp Series C With 1.34M Shares, And Liberty Media Corp Series A With 671.8K Shares

The loss is primarily attributable to a non-cash change in fair value of warrant liabilities related to common share price and warrant price appreciation during the quarter, production restart related operating expenses, and interest expense.

Sable Offshore Reports Q3 Net Income Of $(255.6)M

Marker Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRKR#NASDAQ">MRKR</a>) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.39) by 33.33 percent. The company reported quarterly sales of $1.926 million which beat the analyst consensus estimate of $1.000 million by 92.60 percent. This is a 647.65 percent increase over sales of $257.606 thousand the same period last year.

MRKR

Marker Therapeutics Q3 2024 GAAP EPS $(0.26) Beats $(0.39) Estimate, Sales $1.926M Beat $1.000M Estimate

Zeo Energy (ZEO) has issued an update. On March 13, 2024, an agreement was finalized granting certain shareholders of Zeo Energy Corp ("Zeo") regis...

Zeo Energy's Strategic Restructuring and Nasdaq Listing

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Zeo Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/zeo-stock-quote/">ZEO</a>) just reported results for the first quarter of 2024.<ul><li>Zeo Energy reported earnings per share of -$1.20.</li><li>The company reported revenue of $19.49 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/zeo-stock-earnings-zeo-energy-for-q1-of-2024/">ZEO Stock Earnings: Zeo Energy Reported Results for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

ZEO Stock Earnings: Zeo Energy Reported Results for Q1 2024

Zeo Energy Now Looking For Accelerated Growth Post Its Recent Public Debut

Zeo Energy Makes A Profit Where Rivals Fail, But Be Patient

Crude oil little changed after volatile week with China demand fears lingering

Zeo Energy appoints Cannon Holbrook as CFO

Zeo Energy GAAP EPS of $0.03, revenue of $14.7M

Zeo Energy (ZEO) has issued an update. Cannon Holbrook has been appointed as the new CFO of a prominent company, bringing with him over twenty year...

Zeo Energy Appoints Cannon Holbrook as New CFO

Brent short positions held by money managers exceed longs for first time on record

Zeo Energy ( ($ZEO) ) has shared an update. Zeo Energy Corp. has successfully acquired the majority of Lumio Holdings' assets, including solar ener...

Zeo Energy Strengthens Position with Lumio Acquisition

BOIL

DRIP

GUSH

HNRG

KLXE

KOLD

LAAC

ORLA

PNRG

PPTA

SDST

TALO

USOI

VGAS

WAVE

WFRD

Press Releases

Zeo Energy Corp. Reports Fourth Quarter and Full Year 2023 Financial Results

CORRECTION – Zeo Energy Corp. Reports Fourth Quarter and Full Year 2023 Financial Results

Gateway Group Announces Preliminary Presenting Companies for Gateway Conference in San Francisco on September 4-5, 2024

Zeo Energy Corp. Reports First Quarter 2024 Financial Results

Gateway Group Announces Preliminary Sponsors and Additional Presenting Companies for September Gateway Conference

Management

Zeo Energy Corp. Appoints Cannon Holbrook as Chief Financial Officer

Zeo Energy Corp. Reports Second Quarter 2024 Financial Results

Zeo Energy Corp. to Present at the 2024 Gateway Conference on September 5ᵗʰ

Zeo Energy Corp. and Lumio Complete Sale Transaction

ACNT

AERT

AEYE

AIRG

AMPX

AMRK

ARQQ

ASPN

ATEX

BBSI

BKSY

BREZ

BTBT

BYRN

CAUD

CORZ

CPSS

DEFTF

DUOT

ELVA

FTHM

GAIA

GCTS

GENK

HEAR

HTCR

JTAI

LINK

LTRX

MAPPF

MIGI

MYPS

NATR

ONDS

OOMA

PHUN

PRLB

PXDT

QTRHF

QUISF

SNCR

SNPO

SOWG

SSTI

TRUE

TSX:KITS

TSX:QTRH

TSX:QUIS

TYGO

VTSI

WKHS

ZCAR

Advent Technologies Holdings, Inc. - Class A Common Stock

Advent Technologies Hldgs

Asia Pacific Wire & Cable Corporation Limited - Common shares, Par value .01 per share

Comments

Zeo Energy

Zeo Energy (ZEO) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL